10x Genomics: T. Rowe Price discloses 11.7% stake

10x Genomics, Inc. (TXG) reports that T. Rowe Price Associates, Inc. has filed a Schedule 13G disclosing beneficial ownership of 14,044,020 shares of its Class A common stock, representing 11.7% of the class.

Rhea-AI Filing Summary

10x Genomics, Inc. (TXG) reports that T. Rowe Price Associates, Inc. has filed a Schedule 13G disclosing beneficial ownership of 14,044,020 shares of its Class A common stock, representing 11.7% of the class. T. Rowe Price reports sole voting power over 13,511,751 shares and sole dispositive power over 14,044,020 shares.

T. Rowe Price Associates states that this filing should not be construed as an admission that it is the beneficial owner of these securities and expressly denies such beneficial ownership.

Key Figures

Shares beneficially owned: 14,044,020 shares Percent of class: 11.7% Sole voting power: 13,511,751 shares +3 more

6 metrics

Shares beneficially owned 14,044,020 shares Class A common stock reported by T. Rowe Price Associates on Schedule 13G

Percent of class 11.7% Percentage of 10x Genomics Class A common stock reported as beneficially owned

Sole voting power 13,511,751 shares Shares over which T. Rowe Price Associates has sole power to vote or direct the vote

Shared voting power 0 shares Shares over which T. Rowe Price Associates has shared power to vote

Sole dispositive power 14,044,020 shares Shares over which T. Rowe Price Associates has sole power to dispose or direct disposition

Shared dispositive power 0 shares Shares over which T. Rowe Price Associates has shared dispositive power

Key Terms

Schedule 13G, beneficially owned, Sole Voting Power, Sole Dispositive Power, +1 more

5 terms

Schedule 13G regulatory

"T. Rowe Price Associates, Inc. has filed a Schedule 13G disclosing beneficial ownership"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficially owned financial

"Amount beneficially owned: 14044020"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"Sole Voting Power 13,511,751.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"Sole Dispositive Power 14,044,020.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Percent of class financial

"Percent of class: 11.7 %"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

FAQ

What percentage of 10x Genomics (TXG) shares does T. Rowe Price Associates report owning?

T. Rowe Price Associates reports beneficial ownership of 11.7% of 10x Genomics’ Class A common stock, based on 14,044,020 shares. This ownership and percentage are disclosed in a Schedule 13G filing.

How many 10x Genomics (TXG) shares does T. Rowe Price Associates report as beneficially owned?

T. Rowe Price Associates reports beneficial ownership of 14,044,020 shares of 10x Genomics Class A common stock. This figure is the amount beneficially owned stated in the Schedule 13G under Item 4(a).

What voting power does T. Rowe Price Associates have over its 10x Genomics (TXG) holdings?

T. Rowe Price Associates reports sole voting power over 13,511,751 shares of 10x Genomics and no shared voting power. These numbers come from the Schedule 13G ownership breakdown.

What dispositive power does T. Rowe Price Associates report over its 10x Genomics (TXG) shares?

T. Rowe Price Associates reports sole dispositive power over 14,044,020 shares of 10x Genomics and no shared dispositive power. This indicates it alone can direct the disposition of these reported shares.

Does T. Rowe Price Associates admit beneficial ownership of its reported 10x Genomics (TXG) shares?

No. T. Rowe Price Associates states that the Schedule 13G filing shall not be construed as an admission that it is the beneficial owner of the securities referred to and that such beneficial ownership is expressly denied.

What type of filing did T. Rowe Price Associates make regarding 10x Genomics (TXG)?

T. Rowe Price Associates filed a Schedule 13G concerning 10x Genomics Class A common stock. The filing reports beneficial ownership details, including share count, percentage of class, and voting and dispositive powers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 09:42 AM Accepted by SEC EDGAR 09/08/2026 - 09:42 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

10X GENOMICS INC-CLASS A

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

88025U109

(CUSIP Number)

08/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 88025U109

1

Names of Reporting Persons

T. Rowe Price Associates, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 13,511,751.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 14,044,020.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

14,044,020.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

11.7 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: 10X GENOMICS INC-CLASS A
(b)	Address of issuer's principal executive offices: 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
Item 2.
(a)	Name of person filing: T. Rowe Price Associates, Inc.
(b)	Address or principal business office or, if none, residence: 1307 Point Street, Baltimore, MD 21231
(c)	Citizenship: Maryland
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP Number(s): 88025U109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 14044020
(b)	Percent of class: 11.7 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 13511751
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 14044020
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

T. Rowe Price Associates, Inc.

Signature:	Ellen York
Name/Title:	Vice President
Date:	09/08/2026